Showing results (121-130 of 134) with videos related to
Sort By:
Pageof 14
NEJM Evidence|February 6, 2024
Regulatory T-Cell Response to Low-Dose Interleukin-2 in Ischemic Heart DiseaseTian X Zhao, Rouchelle S Sriranjan, Zewen Kelvin Tuong, et al.Atherosclerosis|May 17, 2005
Circulating levels of MCP-1 and eotaxin are not associated with presence of atherosclerosis or previous myocardial infarctionDavid E Mosedale, Duncan J Smith, Sri Aitken, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 4, 2021
Outcomes following PCI in CABG candidates during the COVID-19 pandemic: The prospective multicentre UK-ReVasc registryThomas A Kite, Andrew Ladwiniec, Colum G Owens, et al.Journal of the American College of Cardiology|June 11, 2025
Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Results of an International Multicenter Prospective RegistryIrene M Lang, Philippe Brenot, Hélène Bouvaist, et al.The American Journal of Cardiology|October 26, 2019
Ascertainment of Silent Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention (from the GLOBAL LEADERS Trial)Chun Chin Chang, Ernest Spitzer, Ply Chichareon, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|June 18, 2011
Leukocyte telomere length is associated with high-risk plaques on virtual histology intravascular ultrasound and increased proinflammatory activityPatrick A Calvert, Tze-Vun Liew, Isabelle Gorenne, et al.European Heart Journal Open|October 18, 2021
Pericoronary and periaortic adipose tissue density are associated with inflammatory disease activity in Takayasu arteritis and atherosclerosisChristopher Wall, Yuan Huang, Elizabeth P V Le, et al.The New England Journal of Medicine|March 30, 2026
Left Ventricular Unloading in High-Risk Percutaneous Coronary InterventionDivaka Perera, Matthew Ryan, Saad M Ezad, et al.The Journal of Invasive Cardiology|March 12, 2024
Complex percutaneous coronary intervention in patients unable to undergo coronary artery bypass grafting during the COVID-19 pandemic: insights from the UK-ReVasc RegistryThomas A Kite, Alexander Chase, Colum G Owens, et al.European Heart Journal|October 7, 2021
Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II studyAdrian P Banning, Patrick Serruys, Giovanni Luigi De Maria, et al.Pageof 14